2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Relationship of Frailty with Kidney Function in Adults More Than 60-Years-Old: Effect of Using Different Formulas to Estimate Glomerular Filtration Rate

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective

          Determine the relationship of renal function with frailty using different formulas for estimated glomerular filtration rate (eGFR).

          Methods

          Individuals who were 60-years-old or more (n=507) were recruited from August 2020 to June 2021, and the FRAIL scale was used to classify them as non-frail or frail. The three equations used to compute the eGFR were based on serum creatinine (eGFRcr), cystatin C (eGFRcys), or SCr+CysC (eGFRcr-cys). Renal function was classified using eGFR and defined as normal (≥90 mL/min/1.73m 2), mild damage (59–89 mL/min/1.73m 2), or moderate damage (≤60 mL/min/1.73m 2). The relationship of frailty with renal function was analyzed. A subset of participants (n=358) was used to analyze changes in eGFR from 1 January 2012 to 31 December 2021 according to frailty and using the different eGFR equations.

          Results

          There were significant differences between the eGFRcr-cys and eGFRcr values in the frail group ( P<0.05), but not the non-frail group; however, the differences between the eGFRcr-cys and eGFRcys values were significant in the frail and non-frail groups ( P<0.001). Based on each eGFR equation, the prevalence of frailty increased as eGFR decreased ( P<0.001), but there was no significant relationship after adjusting for age or the age-adjusted Charlson co-morbidity index. There were temporal declines in eGFR in all three frailty groups (robust, pre-frail, and frail), especially in the frail group (2.226 mL/min/1.73m 2 per year; P<0.001).

          Conclusion

          For older individuals who are frail, the eGFRcr value may not provide accurate estimates of renal function. Frailty is associated with a rapid decline in kidney function.

          Related collections

          Most cited references36

          • Record: found
          • Abstract: not found
          • Article: not found

          Frailty in Older Adults: Evidence for a Phenotype

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline.

            The Kidney Disease: Improving Global Outcomes (KDIGO) organization developed clinical practice guidelines in 2012 to provide guidance on the evaluation, management, and treatment of chronic kidney disease (CKD) in adults and children who are not receiving renal replacement therapy. The KDIGO CKD Guideline Development Work Group defined the scope of the guideline, gathered evidence, determined topics for systematic review, and graded the quality of evidence that had been summarized by an evidence review team. Searches of the English-language literature were conducted through November 2012. Final modification of the guidelines was informed by the KDIGO Board of Directors and a public review process involving registered stakeholders. The full guideline included 110 recommendations. This synopsis focuses on 10 key recommendations pertinent to definition, classification, monitoring, and management of CKD in adults.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Sarcopenia

              Sarcopenia is a progressive and generalised skeletal muscle disorder involving the accelerated loss of muscle mass and function that is associated with increased adverse outcomes including falls, functional decline, frailty, and mortality. It occurs commonly as an age-related process in older people, influenced not only by contemporaneous risk factors, but also by genetic and lifestyle factors operating across the life course. It can also occur in mid-life in association with a range of conditions. Sarcopenia has become the focus of intense research aiming to translate current knowledge about its pathophysiology into improved diagnosis and treatment, with particular interest in the development of biomarkers, nutritional interventions, and drugs to augment the beneficial effects of resistance exercise. Designing effective preventive strategies that people can apply during their lifetime is of primary concern. Diagnosis, treatment, and prevention of sarcopenia is likely to become part of routine clinical practice.
                Bookmark

                Author and article information

                Journal
                Clin Interv Aging
                Clin Interv Aging
                cia
                Clinical Interventions in Aging
                Dove
                1176-9092
                1178-1998
                27 June 2023
                2023
                : 18
                : 999-1007
                Affiliations
                [1 ]Department of Geriatrics, Beijing Friendship Hospital, Capital Medical University , Beijing, People’s Republic of China
                Author notes
                Correspondence: Qing Ma, Email maqing3@163.com
                Author information
                http://orcid.org/0000-0002-3330-6175
                http://orcid.org/0000-0002-6541-6221
                http://orcid.org/0000-0002-5423-0325
                Article
                409140
                10.2147/CIA.S409140
                10314749
                37396789
                fcc8d8bd-3020-4b0b-894d-9a5f739e9174
                © 2023 Shi et al.

                This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.php).

                History
                : 18 February 2023
                : 08 June 2023
                Page count
                Figures: 1, Tables: 11, References: 36, Pages: 9
                Funding
                Funded by: research reported in this publication was funded by the Beijing Municipal Health Commission;
                Funded by: Capital’s Funds for Health Improvement and Research;
                The research reported in this publication was funded by the Beijing Municipal Health Commission (Process No. 19-7) and Capital’s Funds for Health Improvement and Research (CFH 2022-2-2028).
                Categories
                Original Research

                Health & Social care
                elderly,frailty,kidney function,serum creatinine,cystatin c
                Health & Social care
                elderly, frailty, kidney function, serum creatinine, cystatin c

                Comments

                Comment on this article